Multimodal profiling unveils a reversible breast basal-like cell state in AKT-inhibitor resistant tumours

2025/06/07 by Colin D.H. Ratcliffe, Hugh Sparks, Giulia L. M. Boezio +26 · 1 voice
Chemistry · #Click Chemistry and Applications

paper · pdf · doi:10.1101/2025.06.06.658331

Abstract

The PI3K/AKT/mTOR pathway is central to cell metabolism and growth. However, pharmacological inhibition of the pathway is not uniformly effective across cancer types, or even within a single cancer model. In this study, we leverage oblique plane microscopy of triple negative breast cancer organoids, as well as lineage tracing to uncover a source of heterogeneity. Non-genetic resistance to AKT inhibition is associated with basal cell features of normal breast epithelium and the master transcription factor of basal cell state, ΔNp63α, is sufficient to confer resistance. Cells can transition between states within four weeks and therefore, AKT inhibition only delays tumour growth, with tumours rich in KRT14+ cells resulting. Thus, under selection, triple negative breast cancer exploits a repertoire of cell states inherent to the breast.

Discussions

• Organoids in a dish are next to one another. Treatment stops some of them from growing but their neighbours just keep going. What’s the difference? Hint: it’s not genetic doi.org/10.1101/2025... [bsky, 7 points, 0 comments]

Related

• AKT/mTOR Pathway Protein Expression in the Tumor Microenvironment of High-Risk, HR+, and HER2- Breast Cancer using Laser-Capture Microdissection (LCM) and Reverse Phase Protein Arrays (RPPA)
• Triple-Negative Breast Cancer
• A stratification system for breast cancer based on basoluminal tumor cells and spatial tumor architecture
• Mitosis, Cytoskeleton Regulation, and Drug Resistance in Receptor Triple Negative Breast Cancer
• Investigating Phenotypic Plasticity due to Toxicants with Exposure Disparities in Primary Human Breast Cells in Vitro